p53 and Bcl-2 over-expression inversely correlates with histological differentiation in occupational ethmoidal intestinal-type sinonasal adenocarcinoma

International Journal of Immunopathology and Pharmacology

Volumn 24, Issue 3, 2011, Pages 603-609

  Re, M ^a   Magliulo, G ^b   Tarchini, P ^a   Mallardi, V ^a   Rubini, C ^a   Santarelli, A ^a   Lo Muzio, Lorenzo ^c,d  

^a UNIVERSITÀ POLITECNICA DELLE MARCHE   (Italy)

^b SAPIENZA UNIVERSITY OF ROME   (Italy)

^c UNIVERSITY OF FOGGIA   (Italy)

^d REFERRAL CANCER CENTER OF BASILICATA   (Italy)

Author keywords

Adenocarcinoma; Bcl 2; Ethmoid sinus; ITAC; p53

Indexed keywords

PROTEIN BCL 2; PROTEIN P53; ANTIBODY; FORMALDEHYDE; PARAFFIN;

ADULT; AGED; ARTICLE; BCL 2 GENE; CANCER PATIENT; CANCER RELAPSE; CANCER STAGING; CLINICAL ARTICLE; ETHMOID BONE; FEMALE; GENE; GENE EXPRESSION; HISTOLOGY; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INTESTINAL TYPE SINONASAL ADENOCARCINOMA; MALE; NOSE CARCINOMA; OCCUPATIONAL CANCER; OCCUPATIONAL EXPOSURE; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; RETROSPECTIVE STUDY; TP53 GENE; TUMOR DIFFERENTIATION; UPREGULATION; ADENOCARCINOMA; CANCER PROGNOSIS; CANCER RECURRENCE; CONTROLLED STUDY; EMBEDDING; ETHMOID SINUS; ETHMOIDAL INTESTINAL TYPE SINONASAL ADENOCARCINOMA; GENE OVEREXPRESSION; HUMAN CELL; IMMUNOREACTIVITY; INTESTINE CARCINOMA; MIDDLE AGED; PARANASAL SINUS TUMOR; RECEPTOR UPREGULATION; STAINING; TISSUE SECTION; TUMOR LOCALIZATION;

EID: 80055118395     PISSN: 03946320     EISSN: None     Source Type: Journal    
DOI: 10.1177/039463201102400306     Document Type: Article

References (33)

1. Robin PE, Powell DJ, Stansbie JM. Carcinoma of the nasal cavity and paranasal sinuses: incidence and presentation of different histological types. Clin Otolaryngol Allied Sci 1979; 4:431-56. (Pubitemid 10210651)
2. Batsakis JG, Rice DH, Solomon AR. The pathology of head and neck tumors: squamous and mucous--gland carcinomas of the nasal cavity, paranasal sinuses, and larynx, part 6. Head Neck Surg 1980; 2:497-508. (Pubitemid 10085035)
3. Weber AL, Stanton AC. Malignant tumors of the paranasal sinuses: radiologic, clinical, and histopathologic evaluation of 200 cases. Head Neck Surg 1984; 6:761-76. (Pubitemid 14185495)
4. Lopez JI, Nevado M, Eizaguirre B, Perez A. Intestinal-type adenocarcinoma of the nasal cavity and paranasal sinuses. A clinicopathologic study of 6 cases. Tumori 1990; 76:250-4. (Pubitemid 20332817)
5. Kleinsasser O, Schroeder HG. Adenocarcinomas of the inner nose after exposure to wood dust. Morphological findings and relationships between histopathology and clinical behavior in 79 cases. Arch Otorhinolaryngol 1988; 245:1-15.
6. Leclerc A, Martinez Cortes M, Gerin M, Luce D, Brugere J. Sinonasal cancer and wood dust exposure: results from a case-control study. Am J Epidemiol 1994; 140:340-9. (Pubitemid 24257930)
7. Stellman SD, Demers PA, Colin D, Boffetta P. Cancer mortality and wood dust exposure among participants in the American Cancer Society Cancer Prevention Study-II (CPS-II). Am J Ind Med 1998; 34:229-37. (Pubitemid 28364227)
8. Hadfield EH. A study of adenocarcinoma of the paranasal sinuses in woodworkers in the furniture industry. Ann R Coll Surg Engl 1970; 46:301-19.
9. Klintenberg C, Olofsson J, Hellquist H, Sokjer H. Adenocarcinoma of the ethmoid sinuses. A review of 28 cases with special reference to wood dust exposure. Cancer 1984; 54:482-8. (Pubitemid 14087878)
10. Barnes L. Intestinal-type adenocarcinoma of the nasal cavity and paranasal sinuses. Am J Surg Pathol 1986; 10:192-202. (Pubitemid 16055157)
11. Franchi A, Gallo O, Santucci M. Clinical relevance of the histological classification of sinonasal intestinal-type adenocarcinomas. Hum Pathol 1999; 30:1140-5. (Pubitemid 29480880)
12. Mills SE, Fechner RE, Cantrell RW. Aggressive sinonasal lesion resembling normal intestinal mucosa. Am J Surg Pathol 1982; 6:803-9. (Pubitemid 13176299)
13. Batsakis JG, Mackay B, Ordonez NG. Enteric-type adenocarcinoma of the nasal cavity. An electron microscopic and immunocytochemical study. Cancer 1984; 54:855-60. (Pubitemid 14058440)
14. McKinney CD, Mills SE, Franquemont DW Sinonasal intestinal-type adenocarcinoma: immunohistochemical profile and comparison with colonic adenocarcinoma. Mod Pathol 1995; 8:421-6.
15. Franchi A, Massi D, Baroni G, Santucci M. CDX-2 homeobox gene expression. Am J Surg Pathol 2003; 27:1390-1. (Pubitemid 37185832)
16. Fearon ER, Vogelstein B. A genetic model for colorectal tumorigenesis. Cell 1990; 61:759-67.
17. Chung DC. The genetic basis of colorectal cancer: insights into critical pathways of tumorigenesis. Gastroenterology 2000; 119:854-65.
18. Saber AT, Nielsen LR, Dictor M, Hagmar L, Mikoczy Z, Wallin H. K-ras mutations in sinonasal adenocarcinomas in patients occupationally exposed to wood or leather dust. Cancer Lett 1998; 126:59-65. (Pubitemid 28142972)
19. Perez P, Dominguez O, Gonzalez S, Trivino A, Suarez C. Ras gene mutations in ethmoid sinus adenocarcinoma: prognostic implications. Cancer 1999; 86:255-64. (Pubitemid 29327582)
20. Wu TT, Barnes L, Bakker A, Swalsky PA, Finkelstein SD. K-ras-2 and p53 genotyping of intestinal-type adenocarcinoma of the nasal cavity and paranasal sinuses. Mod Pathol 1996; 9:199-204. (Pubitemid 26126544)
21. Perrone F, Oggionni M, Birindelli S, Suardi S, Tabano S, Romano R. TP53, p14ARF, p16INK4a and H-ras gene molecular analysis in intestinal-type adenocarcinoma of the nasal cavity and paranasal sinuses. Int J Cancer 2003; 105:196-203. (Pubitemid 36505321)
22. Gallo O, Franchi A, Fini-Storchi I, Cilento G, Boddi V, Boccuzzi S. Prognostic significance of c-erbB-2 oncoprotein expression in intestinal-type adenocarcinoma of the sinonasal tract. Head Neck 1998; 20:224-31. (Pubitemid 28169734)
23. Soussi T, Beroud C. Assessing TP53 status in human tumours to evaluate clinical outcome. Nat Rev Cancer 2001; 1:233-40. (Pubitemid 33741898)
24. Reed JC. Dysregulation of apoptosis in cancer. J Clin Oncol 1999; 17:2941-53. (Pubitemid 29415256)
25. Friedman M, Lim JW, Manders E, Schaffner AD, Kirshenbaum GL, Tanyeri HM. Prognostic significance of Bcl-2 and p53 expression in advanced laryngeal squamous cell carcinoma. Head Neck 2001; 23:280-5. (Pubitemid 32234104)
26. Jin YT, Kayser S, Kemp BL, Ordonez NG, Tucker SL, Clayman GL. The prognostic significance of the biomarkers p21WAF1/CIP1, p53, and bcl-2 in laryngeal squamous cell carcinoma. Cancer 1998; 82:2159-65. (Pubitemid 28240822)
27. Jackel MC, Sellmann L, Dorudian MA, Youssef S, Fuzesi L. Prognostic significance of p53/bcl-2 co-expression in patients with laryngeal squamous cell carcinoma. Laryngoscope 2000; 110:1339-45. (Pubitemid 30626103)
28. Wilson GD, Graver R, Richman PI, Daley FM, Saunders MI, Dische S. Bcl-2 expression correlates with favourable outcome in head and neck cancer treated by accelerated radiotherapy. Anticancer Res 1996; 16:2403-8. (Pubitemid 26326270)
29. Xie X, Clausen OP, De Angelis P, Boysen M. The prognostic value of spontaneous apoptosis, Bax, Bcl-2, and p53 in oral squamous cell carcinoma of the tongue. Cancer 1999; 86:913-20. (Pubitemid 29439843)
30. Calvert PM, Frucht H. The genetics of colorectal cancer. Ann Intern Med 2002; 137:603-12.
31. Licitra L, Suardi S, Bossi P, Locati LD, Mariani L, Quattrone P. Prediction of TP53 status for primary cisplatin, fluorouracil, and leucovorin chemotherapy in ethmoid sinus intestinal-type adenocarcinoma. J Clin Oncol 2004; 22:4901-6. (Pubitemid 46638614)
32. Perez-Ordonez B, Huynh NN, Berean KW, Jordan RC. Expression of mismatch repair proteins, beta catenin, and E Cadherin in intestinal-type sinonasal adenocarcinoma. J Clin Pathol 2004; 57:1080-3. (Pubitemid 39331360)
33. Kennedy MT, Jordan RC, Berean KW, Perez-Ordonez B. Expression pattern of CK7, CK20, CDX-2, and villin in intestinal-type sinonasal adenocarcinoma. J Clin Pathol 2004; 57:932-7. (Pubitemid 39208243)